ARYA Sciences Acquisition Corp IV (ARYD) to Combine with Caritas Therapeutics in $242M Deal
Warning: DOMDocument::loadHTML(): Unexpected end tag : p in Entity, line: 5 in /var/convesio/wordpress/wp-content/plugins/spacinsider-upqode/src/Start.php on line 90
ARYA IV (NASDAQ:ARYD) has entered into a definitive agreement to combine with Amicus (NASDAQ:FOLD)’s gene therapy business to create a separate entity called Caritas Therapeutics with an enterprise value of $242.3 million. This division of Philadelphia-based Amicus is developing a series of gene therapies to treat rare genetic disorders that primarily afflict children and carry
Read More